Alkermes' Sleeping Disorder Studies' Data Look Excellent, Analyst Says
On Tuesday, Alkermes plc ALKS revealed topline results from the narcolepsy type 2 (NT2) and idiopathic hypersomnia (IH) cohorts of a phase 1b, proof-of-concept study evaluating ALKS 2680 for narcolepsy. ALKS 2680 data demonstrated clinically meaningful and statistically significant improvements…#alkermesplcalks #alks2680 #mwt #alks #placebo #ih #jefferies #alkermesalks2680 (Source: Reuters: Health)
Source: Reuters: Health - April 9, 2024 Category: Consumer Health News Source Type: news
How to tell if you have the sleep disorder that even doctors don't know about
Do you struggle to get out of bed without an alarm clock, then feel tired all day? You might assume this is caused by lack of sleep, yet for some people it can be a sign of idiopathic hypersomnia. (Source: the Mail online | Health)
Source: the Mail online | Health - April 9, 2024 Category: Consumer Health News Source Type: news
Wake up tired after hours of rest? You may have a sleep disorder that even doctors don't know about
Do you struggle to get out of bed without an alarm clock, then feel tired all day? You might assume this is caused by lack of sleep, yet for some people it can be a sign of idiopathic hypersomnia. (Source: the Mail online | Health)
Source: the Mail online | Health - April 9, 2024 Category: Consumer Health News Source Type: news
Zevra Therapeutics Announces Top-Line Data from the Phase 2 Clinical Trial of KP1077 for Idiopathic Hypersomnia
Top-line data provide key information for the design of a Phase 3 study CELEBRATION, Fla., March 26, 2024 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. ZVRA (Zevra, or the Company) a rare disease therapeutics company, today announced top-line data from its placebo-controlled, double-blind Phase 2…#celebration #fla #zevra #phase2 #nct05668754 #kp1077 #zevraphase2 #ih #christopherdrake #phd (Source: Reuters: Health)
Source: Reuters: Health - March 26, 2024 Category: Consumer Health News Source Type: news
Idiopathic hypersomnia with a video recording of a spontaneous sleep attack: a case report - Asaga T, Hashimoto K, Kawamura Y, Fujita N, Kimata M, Sekizawa A, Ono Y, Obuchi Y, Kobayashi N, Hirasawa H, Kanbayashi T, Tanaka Y.
RATIONALE: Although patients with central disorders of hypersomnolence (CDH) exhibit characteristic symptoms of hypersomnia frequently, it takes 5 to 15 years from the onset for its diagnosis due to the lack of symptom recognition. Here, we present a case ... (Source: SafetyLit)
Source: SafetyLit - February 19, 2024 Category: International Medicine & Public Health Tags: Distraction, Fatigue, Chronobiology, Vigilance, Workload Source Type: news
Estimated Prevalence of Idiopathic Hypersomnia 1.5 Percent
THURSDAY, Dec. 14, 2023 -- Idiopathic hypersomnia (IH) has an estimated prevalence of 1.5 percent, according to a study published online Dec. 13 in Neurology.
David T. Plante, M.D., Ph.D., from the University of Wisconsin-Madison, and colleagues... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 14, 2023 Category: Pharmaceuticals Source Type: news
Nearly 5MILLION Americans have little-known sleep disorder that leaves people exhausted even after getting 8 hours of rest a night, scientists say
Researchers in the US estimated that as many as one in 70 individuals, or nearly 5million Americans, have 'idiopathic hypersomnia' - far more than previously thought. (Source: the Mail online | Health)
Source: the Mail online | Health - December 13, 2023 Category: Consumer Health News Source Type: news
Heart Risks Much Higher for Patients With Rare Sleep Disorder
(MedPage Today) -- NASHVILLE, Tenn. -- Individuals with idiopathic hypersomnia may face a greater likelihood of heart-related events, a retrospective cohort study suggested.
Compared with matched controls without the rare sleep disorder, patients... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - September 11, 2023 Category: Cardiology Source Type: news
Stimulating hypocretin receptors improves sleepiness and vigilance in idiopathic hypersomnia: lessons from a proof of concept study - Arnulf I, Maranci JB.
[Abstract unavailable]
Language: en... (Source: SafetyLit)
Source: SafetyLit - May 22, 2023 Category: International Medicine & Public Health Tags: Commentary Source Type: news
Puzzling Causes
If you live with idiopathic hypersomnia, you’d probably like to know what’s causing it. Unfortunately, that’s not something experts have figured out yet. (Source: WebMD Health)
Source: WebMD Health - October 19, 2022 Category: Consumer Health News Source Type: news
Advice to Adjust to Life
If you have idiopathic hypersomnia, you might need medication, talk therapy, or lifestyle changes. It can be a challenge to adjust to life with IH. But there are strategies that can help. (Source: WebMD Health)
Source: WebMD Health - October 19, 2022 Category: Consumer Health News Source Type: news
Woman reveals how rare sleep disorder has robbed her of 'so many years'
Helena Smythe, of Cambridgeshire, has idiopathic hypersomnia, a narcolepsy-like condition that is sometimes called 'excessive daytime sleepiness'. (Source: the Mail online | Health)
Source: the Mail online | Health - March 23, 2022 Category: Consumer Health News Source Type: news
First FDA-Approved Hypersomnia Drug Data Published First FDA-Approved Hypersomnia Drug Data Published
Lower-sodium oxybate improves idiopathic hypersomnia symptoms and might be a useful first-line therapy or monotherapy or used in combination with alerting agents, newly published data show.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - January 18, 2022 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news
Comparing objective wakefulness and vigilance tests to on-the-road driving performance in narcolepsy and idiopathic hypersomnia - Bijlenga D, Urbanus B, van der Sluiszen NNJJM, Overeem S, Ramaekers JG, Vermeeren A, Lammers GJ.
Patients with narcolepsy or idiopathic hypersomnia (IH) are at increased risk of driving accidents. Both excessive daytime sleepiness, i.e. unwanted sleep episodes during the day, and disturbed vigilance are core features of these disorders. We tested on-t... (Source: SafetyLit)
Source: SafetyLit - November 15, 2021 Category: International Medicine & Public Health Tags: Distraction, Fatigue, Chronobiology, Vigilance, Workload Source Type: news
Xywav Gets FDA Approval to Treat Rare Sleep Disorder
FRIDAY, Aug. 13, 2021 -- The drug Xywav has been approved for expanded use in adults with the rare sleep disorder idiopathic hypersomnia, the U.S. Food and Drug Administration said Thursday.
It is the first drug to be approved by the FDA for... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 13, 2021 Category: Pharmaceuticals Source Type: news
